{"id":"W2620369605","doi":"10.1016/s0140-6736(17)31429-0","title":"Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Eli Lilly and Company","keywords":"Psoriatic arthritis; Medicine; Ixekizumab; Double blind; Placebo; Arthritis; Psoriasis; Placebo-controlled study; Internal medicine; Dermatology; Alternative medicine; Pathology; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002620547,0.001127361,0.00263878,0.0002899413,0.0002892507,0.001055501,0.0006840241,0.001559115,0.003187272],"category_scores_gemma":[0.002393532,0.0004678344,0.003138811,0.0003616162,0.0009269561,0.001063813,0.0004037332,0.002611295,0.0005583809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006304652,"about_ca_system_score_gemma":0.0007502635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000803544,"about_ca_topic_score_gemma":0.001646536,"domain_scores_codex":[0.9991641,0.0004674344,0.00006505777,0.0001145361,0.00006953821,0.0001193633],"domain_scores_gemma":[0.9988469,0.0003946846,0.0003207923,0.0001145852,0.00006421104,0.0002588603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9649259,0.001871233,0.001279213,0.001374436,0.002557401,0.00004606563,0.00006587531,0.000262143,0.002583725,0.00009173143,0.001089336,0.02385278],"study_design_scores_gemma":[0.9611835,0.03062114,0.005509756,0.00007215068,0.001102997,0.00006557396,0.0000359208,0.0001849287,0.0002801652,0.0001496165,0.0007753946,0.00001889041],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9758651,0.01918291,0.0005084256,0.0009544535,0.0004780297,0.0006590377,0.0008519645,0.00008358924,0.001416407],"genre_scores_gemma":[0.989419,0.005612985,0.0007334111,0.001117617,0.0004006105,0.0005469113,0.0009418515,0.00002124323,0.001206326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003187272,"threshold_uncertainty_score":0.01385897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05279562354982375,"score_gpt":0.3222825524133971,"score_spread":0.2694869288635733,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}